Sponsored Links

Simvastatin Can Injure Muscle At High Dose, FDA PDF Print E-mail
Pharmacy - Pharma Industry - Biotech Industry
The highest approved dose (80 mg) of the cholesterol-lowering drug simvastatin, is tied to higher risk of myopathy or muscle injury, including its most serious form rhabdomyolysis. This is particularly significant in the first 12 months of use, said the US Food and Drug Administration (FDA), who announced safety label changes yesterday...

Read more: Pharma Industry / Biotech Industry News From Medical News Today